Cargando…

Risk factors for cardiovascular disease in patients with COPD: mild-to-moderate COPD versus severe-to-very severe COPD

OBJECTIVE: To assess and compare the prevalence of comorbidities and risk factors for cardiovascular disease (CVD) in COPD patients according to disease severity. METHODS: The study included 25 patients with mild-to-moderate COPD (68% male; mean age, 65 ± 8 years; mean FEV(1), 73 ± 15% of predicted)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Caram, Laura Miranda de Oliveira, Ferrari, Renata, Naves, Cristiane Roberta, Coelho, Liana Sousa, do Vale, Simone Alves, Tanni, Suzana Erico, Godoy, Irma
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Pneumologia e Tisiologia 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5569610/ https://www.ncbi.nlm.nih.gov/pubmed/27383930 http://dx.doi.org/10.1590/S1806-37562015000000121

Ejemplares similares

Association between left ventricular diastolic dysfunction and severity of chronic obstructive pulmonary disease
por: de Oliveira Caram, Laura Miranda, et al.
Publicado: (2013)

Assessment of Aerobic Exercise Adverse Effects during COPD Exacerbation Hospitalization
por: Knaut, Caroline, et al.
Publicado: (2017)

Smoking and Early COPD as Independent Predictors of Body Composition, Exercise Capacity, and Health Status
por: Caram, Laura Miranda de Oliveira, et al.
Publicado: (2016)

Impact of adherence to long-term oxygen therapy on patients with COPD and exertional hypoxemia followed for one year
por: Mesquita, Carolina Bonfanti, et al.
Publicado: (2018)

November 18: World COPD Day 2020. Is it a date to celebrate?
por: Batista, Diane Rezende, et al.
Publicado: (2020)

DNA damage and antioxidant capacity in COPD patients with and without lung cancer
por: dos Santos, Camila Freitas, et al.
Publicado: (2022)

Predictors of mortality in patients with COPD after 9 years
por: Prudente, Robson, et al.
Publicado: (2018)

Relation between systemic inflammatory markers, peripheral muscle mass, and strength in limb muscles in stable COPD patients
por: Ferrari, Renata, et al.
Publicado: (2015)

Peripheral Blood Eosinophils and Nine Years Mortality in COPD Patients
por: Prudente, Robson, et al.
Publicado: (2021)

Predictors of health status do not change over three-year periods and exacerbation makes difference in chronic obstructive pulmonary disease
por: Ferrari, Renata, et al.
Publicado: (2011)

Early efficacy of budesonide/formoterol in patients with moderate-to-very-severe COPD
por: Calverley, Peter M, et al.
Publicado: (2016)

Tumor necrosis factor receptor 2 as a possible marker of COPD in smokers and ex-smokers
por: Caram, Laura Miranda de Oliveira, et al.
Publicado: (2017)

Smoking status and tumor necrosis factor-alpha mediated systemic inflammation in COPD patients
por: Tanni, Suzana E, et al.
Publicado: (2010)

Sarcopenia in COPD: relationship with COPD severity and prognosis
por: Costa, Tatiana Munhoz da Rocha Lemos, et al.
Publicado: (2015)

The Level of Cholesterol in COPD Patients with Severe and Very Severe Stage of the Disease
por: Zafirova-Ivanovska, Beti, et al.
Publicado: (2016)

Symptom profiles and inflammatory markers in moderate to severe COPD
por: Nguyen, Huong Q., et al.
Publicado: (2016)

A Post Hoc Holter ECG Analysis of Olodaterol and Formoterol in Moderate-to-Very-Severe COPD
por: Andreas, Stefan, et al.
Publicado: (2020)

Impact of cardiovascular comorbidities on COPD Assessment Test (CAT) and its responsiveness to pulmonary rehabilitation in patients with moderate to very severe COPD: protocol of the Chance study
por: Smid, Dionne E, et al.
Publicado: (2015)

The Prevalence of Diabetes Mellitus in COPD Patients with Severe and Very Severe Stage of the Disease
por: Stojkovikj, Jagoda, et al.
Publicado: (2016)

Plasma homocysteine is elevated in COPD patients and is related to COPD severity
por: Seemungal, Terence AR, et al.
Publicado: (2007)

Phenotype of Asthma-COPD Overlap in COPD and Severe Asthma Cohorts
por: Joo, Hyonsoo, et al.
Publicado: (2022)

Heterogeneity in the respiratory symptoms of patients with mild-to-moderate COPD
por: Johnson, Kate M, et al.
Publicado: (2018)

Factors associated with exacerbation in mild- to-moderate COPD patients
por: Kim, Joo Kyung, et al.
Publicado: (2016)

In Patients with Mild-to-Moderate COPD, Tobacco Smoking, and Not COPD, Is Associated with a Higher Risk of Cardiovascular Comorbidity
por: Soumagne, Thibaud, et al.
Publicado: (2020)

Evaluation of Inflammatory Markers in Patients Undergoing a Short-Term Aerobic Exercise Program while Hospitalized due to Acute Exacerbation of COPD
por: Knaut, Caroline, et al.
Publicado: (2020)

Acute bronchodilator responses decline progressively over 4 years in patients with moderate to very severe COPD
por: Tashkin, Donald P, et al.
Publicado: (2014)

Long-term safety of tiotropium/olodaterol in older patients with moderate-to-very-severe COPD in the TONADO® studies
por: Ferguson, Gary T., et al.
Publicado: (2020)

COPD assessment test and severity of airflow limitation in patients with asthma, COPD, and asthma–COPD overlap syndrome
por: Kurashima, Kazuyoshi, et al.
Publicado: (2016)

Profile of glycopyrronium for once-daily treatment of moderate-to-severe COPD
por: Buhl, Roland, et al.
Publicado: (2012)

Aclidinium Bromide: Clinical Benefit in Patients with Moderate to Severe COPD
por: Suppli Ulrik, Charlotte
Publicado: (2012)

Symptoms and impact of COPD assessed by an electronic diary in patients with moderate-to-severe COPD: psychometric results from the SHINE study
por: Kulich, Károly, et al.
Publicado: (2015)

Arginines Plasma Concentration and Oxidative Stress in Mild to Moderate COPD
por: Zinellu, Angelo, et al.
Publicado: (2016)

Cost-effectiveness analysis of umeclidinium/vilanterol for the management of patients with moderate to very severe COPD using an economic model
por: Wilson, Michele R, et al.
Publicado: (2017)

Effect of Erdosteine on COPD Exacerbations in COPD Patients with Moderate Airflow Limitation
por: Calverley, Peter MA, et al.
Publicado: (2019)

Profile of glycopyrronium for once-daily treatment of moderate-to-severe COPD [Corrigendum]
Publicado: (2014)

Targeted lung denervation for moderate to severe COPD: a pilot study
por: Slebos, Dirk-Jan, et al.
Publicado: (2015)

Determinants of change in physical activity during moderate-to-severe COPD exacerbation
por: Esteban, Cristóbal, et al.
Publicado: (2016)

Effects of Tai Chi on patients with moderate to severe COPD in stable phase
por: Luo, Chengfang, et al.
Publicado: (2022)

Cost-effectiveness of roflumilast in combination with bronchodilator therapies in patients with severe and very severe COPD in Switzerland
por: Samyshkin, Yevgeniy, et al.
Publicado: (2013)

Impacts of coexisting bronchial asthma on severe exacerbations in mild-to-moderate COPD: results from a national database
por: Lee, Hyun, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_dda4m30mcqnhtdm4n8nqnofmnd